Across TCGA pan-cancer cohorts, TP53TG3 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TP53TG3’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where TP53TG3 RNA is repressed in tumor relative to normal tissue. In most cancer types TP53TG3 is over-expressed in tumor, although a few such as UCEC and KIRC show the opposite, repressed pattern.

UCEC, LUSC, and KIRC are the cancer types where TP53TG3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TP53TG3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.007	.018	2	view →
LUSC	All	All	+0.006	.001	2	view →
KIRC	All	All	−0.002	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: TP53TG3 RNA expression & survival · all TP53TG3 data types